International Patent Strategies for Biopharmaceutical SMEs in Canada
This report was commissioned by Industry Canada to examine the current state of international patent strategies for biopharmaceutical small and medium-sized enterprises (SMEs). It provides an overview of typical patent strategies of SMEs, and includes some of the “best practice” international patent strategies that Canadian biopharmaceutical SMEs can use to position themselves favourably to attract venture capital investment and pharmaceutical partners. Patent checklists that are typically used by investors and Big Pharma to evaluate the patent programs of SMEs are included. Strategic considerations for developing a biopharmaceutical SME’s patent program and budgets are also addressed.